Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
Department of Surgery, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.
BJS Open. 2020 Jun;4(3):508-515. doi: 10.1002/bjs5.50274. Epub 2020 Apr 3.
Although R0 surgery is recommended for stage IV colorectal cancer, the degree of required lymphadenectomy has not been established. The aim of this study was to investigate the prognostic impact of high ligation (HL) of the feeding artery and the number of retrieved lymph nodes after R0 surgery for colorectal cancer and synchronous colorectal cancer liver metastasis (CRLM).
This was a multi-institutional retrospective analysis of patients with colorectal cancer and synchronous CRLM who had R0 surgery between January 1997 and December 2007. Clinical and pathological features were compared in patients who underwent HL and those who had a low ligation (LL). Kaplan-Meier analysis was performed to estimate the effect of HL on overall survival (OS). The impact of several risk factors on survival was analysed using the Cox proportional hazards model.
Of 549 patients, 409 (74·5 per cent) had HL. Median follow-up was 51·4 months. HL significantly improved the 5-year OS rate (58·2 per cent versus 49·3 per cent for LL; P = 0·017). Multivariable analysis revealed HL to be a significant prognostic factor compared with LL (5-year mortality: hazard ratio (HR) 0·68, 95 per cent c.i. 0·51 to 0·90; P = 0·007). In subgroup analysis, the positive effect of HL on OS was greatest in patients with lymph node metastasis.
HL of the feeding artery was associated with improved OS in patients with colorectal cancer and synchronous CRLM after R0 surgery.
尽管推荐对 IV 期结直肠癌进行 R0 手术,但尚未确定所需的淋巴结清扫程度。本研究旨在探讨结直肠癌和同步结直肠癌肝转移(CRLM)患者接受 R0 手术后,高位结扎(HL)和淋巴结检出数对预后的影响。
这是一项多机构回顾性分析,纳入 1997 年 1 月至 2007 年 12 月接受 R0 手术的结直肠癌和同步 CRLM 患者。比较了行 HL 和低位结扎(LL)的患者的临床和病理特征。采用 Kaplan-Meier 分析估计 HL 对总生存(OS)的影响。采用 Cox 比例风险模型分析了几个危险因素对生存的影响。
549 例患者中,409 例(74.5%)行 HL。中位随访时间为 51.4 个月。HL 显著提高了 5 年 OS 率(HL 组为 58.2%,LL 组为 49.3%;P=0.017)。多变量分析显示,与 LL 相比,HL 是一个显著的预后因素(5 年死亡率:风险比(HR)0.68,95%可信区间 0.51 至 0.90;P=0.007)。亚组分析显示,在有淋巴结转移的患者中,HL 对 OS 的积极影响最大。
在接受 R0 手术的结直肠癌和同步 CRLM 患者中,结扎肿瘤供血动脉可改善 OS。